Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Malignant Melanoma

Free Subscription Articles published in J Clin Invest Retrieve available abstracts of 24 articles: HTML format Text format

Single Articles

April 2018
1. NSENGIMANA J, Laye J, Filia A, O'Shea S, et al
   beta-Catenin-mediated immune evasion pathway frequently operates in primary cutaneous melanomas.
   J Clin Invest. 2018 Apr 16. pii: 95351. doi: 10.1172/JCI95351.
   PubMed     Text format     Abstract available
   
   
   January 2018
2. VEATCH JR, Lee SM, Fitzgibbon M, Chow IT, et al
   Tumor infiltrating BRAFV600E-specific CD4 T cells correlated with complete clinical response in melanoma.
   J Clin Invest. 2018 Jan 23. pii: 98689. doi: 10.1172/JCI98689.
   PubMed     Text format     Abstract available
   
   
   December 2017
3. TAMIYA H, Kim H, Klymenko O, Kim H, et al
   SHARPIN-mediated regulation of protein arginine methyltransferase 5 controls melanoma growth.
   J Clin Invest. 2017 Dec 11. pii: 95410. doi: 10.1172/JCI95410.
   PubMed     Text format     Abstract available
   
   
   
4. VENKATESAN AM, Vyas R, Gramann AK, Dresser K, et al
   Ligand-activated BMP signaling inhibits cell differentiation and death to promote melanoma.
   J Clin Invest. 2017 Dec 4. pii: 92513. doi: 10.1172/JCI92513.
   PubMed     Text format     Abstract available
   
   
   October 2017
5. ZHAN Y, Guo J, Yang W, Goncalves C, et al
   MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma.
   J Clin Invest. 2017 Oct 16. pii: 91258. doi: 10.1172/JCI91258.
   PubMed     Text format     Abstract available
   
   
   August 2017
6. JESCHKE J, Bizet M, Desmedt C, Calonne E, et al
   DNA methylation-based immune response signature improves patient diagnosis in multiple cancers.
   J Clin Invest. 2017;127:3090-3102.
   PubMed     Text format     Abstract available
   
   
   
7. AYERS M, Lunceford J, Nebozhyn M, Murphy E, et al
   IFN-gamma-related mRNA profile predicts clinical response to PD-1 blockade.
   J Clin Invest. 2017;127:2930-2940.
   PubMed     Text format     Abstract available
   
   
   June 2017
8. SMITH TT, Moffett HF, Stephan SB, Opel CF, et al
   Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors.
   J Clin Invest. 2017;127:2176-2191.
   PubMed     Text format     Abstract available
   
   
   May 2017
9. OLVEDY M, Tisserand JC, Luciani F, Boeckx B, et al
   Comparative oncogenomics identifies tyrosine kinase FES as a tumor suppressor in melanoma.
   J Clin Invest. 2017 May 2. pii: 91291. doi: 10.1172/JCI91291.
   PubMed     Text format     Abstract available
   
   
   April 2017
10. ANSA-ADDO EA, Zhang Y, Yang Y, Hussey GS, et al
    Membrane-organizing protein moesin controls Treg differentiation and antitumor immunity via TGF-beta signaling.
    J Clin Invest. 2017;127:1321-1337.
    PubMed     Text format     Abstract available
    
    
    September 2016
11. JANOWSKI AM, Colegio OR, Hornick EE, McNiff JM, et al
    NLRC4 suppresses melanoma tumor progression independently of inflammasome activation.
    J Clin Invest. 2016 Sep 12. pii: 86953. doi: 10.1172/JCI86953.
    PubMed     Text format     Abstract available
    
    
    August 2016
12. LUND AW, Wagner M, Fankhauser M, Steinskog ES, et al
    Lymphatic vessels regulate immune microenvironments in human and murine melanoma.
    J Clin Invest. 2016 Aug 15. pii: 79434. doi: 10.1172/JCI79434.
    PubMed     Text format     Abstract available
    
    
    
13. DAUD AI, Loo K, Pauli ML, Sanchez-Rodriguez R, et al
    Tumor immune profiling predicts response to anti-PD-1 therapy in human melanoma.
    J Clin Invest. 2016 Aug 15. pii: 87324. doi: 10.1172/JCI87324.
    PubMed     Text format     Abstract available
    
    
    February 2016
14. JACQUELOT N, Enot DP, Flament C, Vimond N, et al
    Chemokine receptor patterns in lymphocytes mirror metastatic spreading in melanoma.
    J Clin Invest. 2016 Feb 8. pii: 80071. doi: 10.1172/JCI80071.
    PubMed     Text format     Abstract available
    
    
    January 2016
15. LEISEGANG M, Kammertoens T, Uckert W, Blankenstein T, et al
    Targeting human melanoma neoantigens by T cell receptor gene therapy.
    J Clin Invest. 2016 Jan 25. pii: 83465. doi: 10.1172/JCI83465.
    PubMed     Text format     Abstract available
    
    
    
16. KLEBANOFF CA, Scott CD, Leonardi AJ, Yamamoto TN, et al
    Memory T cell-driven differentiation of naive cells impairs adoptive immunotherapy.
    J Clin Invest. 2016;126:318-34.
    PubMed     Text format     Abstract available
    
    
    
17. DEWAELE M, Tabaglio T, Willekens K, Bezzi M, et al
    Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growth.
    J Clin Invest. 2016;126:68-84.
    PubMed     Text format     Abstract available
    
    
    November 2015
18. KNIGHT DA, Ngiow SF, Li M, Parmenter T, et al
    Host immunity contributes to the anti-melanoma activity of BRAF inhibitors.
    J Clin Invest. 2015 Nov 23. pii: 84828. doi: 10.1172/JCI84828.
    PubMed     Text format    
    
    
    
19. KURTULUS S, Sakuishi K, Ngiow SF, Joller N, et al
    TIGIT predominantly regulates the immune response via regulatory T cells.
    J Clin Invest. 2015;125:4053-62.
    PubMed     Text format     Abstract available
    
    
    October 2015
20. COHEN CJ, Gartner JJ, Horovitz-Fried M, Shamalov K, et al
    Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes.
    J Clin Invest. 2015;125:3981-91.
    PubMed     Text format     Abstract available
    
    
    
21. HURST JH
    Cancer immunotherapy innovator James Allison receives the 2015 Lasker~DeBakey Clinical Medical Research Award.
    J Clin Invest. 2015;125:3732-6.
    PubMed     Text format    
    
    
    September 2015
22. BUCHBINDER E, Hodi FS
    Cytotoxic T lymphocyte antigen-4 and immune checkpoint blockade.
    J Clin Invest. 2015;125:3377-83.
    PubMed     Text format     Abstract available
    
    
    May 2015
23. POLLIZZI KN, Patel CH, Sun IH, Oh MH, et al
    mTORC1 and mTORC2 selectively regulate CD8(+) T cell differentiation.
    J Clin Invest. 2015;125:2090-108.
    PubMed     Text format     Abstract available
    
    
    
24. MCCRACKEN MN, Vatakis DN, Dixit D, McLaughlin J, et al
    Noninvasive detection of tumor-infiltrating T cells by PET reporter imaging.
    J Clin Invest. 2015;125:1815-26.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: